Cargando…
Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.
The effect of nitric oxide-dependent vasodilators on vascular resistance of tumours and normal tissue was determined with the aim of modifying tumour blood flow for therapeutic benefit. Isolated preparations of the rat P22 tumour and normal rat hindlimb were perfused ex vivo. The effects on tissue v...
Autores principales: | Tozer, G. M., Prise, V. E., Bell, K. M., Dennis, M. F., Stratford, M. R., Chaplin, D. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074803/ https://www.ncbi.nlm.nih.gov/pubmed/8980396 |
Ejemplares similares
-
The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
por: Cemazar, M, et al.
Publicado: (2005) -
Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
por: Tozer, G. M., et al.
Publicado: (1994) -
Modification of tumour blood flow using the hypertensive agent, angiotensin II.
por: Tozer, G. M., et al.
Publicado: (1993) -
Arsenic-induced dysfunction in relaxation of blood vessels.
por: Lee, Moo-Yeol, et al.
Publicado: (2003) -
The effects of hyperoxic and hypercarbic gases on tumour blood flow
por: Dunn, T J, et al.
Publicado: (1999)